Microparticle and mitochondrial release during extended storage of different types of platelet concentrates

Platelets

Volumn 28, Issue 3, 2017, Pages 272-280

  Marcoux, Geneviève ^a,b   Duchez, Anne Claire ^a   Rousseau, Matthieu ^a   Lévesque, Tania ^a   Boudreau, Luc H ^a   Thibault, Louis ^a,b   Boilard, Eric ^a  

^a LAVAL UNIVERSITY   (Canada)

^b HÉMA QUÉBEC   (Canada)

Author keywords

Microparticles; mitochondria; platelet concentrates; SPADE; storage; transfusion

Indexed keywords

GLUCOSE; LACTIC ACID; MITOCHONDRIAL DNA; THROMBOCYTE CONCENTRATE; BIOLOGICAL MARKER; LIPOCORTIN 5; MITOTRACKER RED 580; ORGANIC COMPOUND; PADGEM PROTEIN; SELP PROTEIN, HUMAN; THROMBIN;

ALGORITHM; APHERESIS; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD ANALYSIS; BLOOD BANK; BLOOD BUFFY COAT; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; MITOCHONDRION; NORMAL HUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SPANNING TREE PROGRESSION ANALYSIS OF DENSITY NORMALIZED EVENT; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; TIME TO TREATMENT; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MEMBRANE MICROPARTICLE; METABOLISM; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTOPHERESIS;

ANNEXIN A5; BIOMARKERS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; HUMANS; MITOCHONDRIA; ORGANIC CHEMICALS; P-SELECTIN; PLATELET ACTIVATION; PLATELET-RICH PLASMA; PLATELETPHERESIS; THROMBIN;

EID: 84989267233     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1218455     Document Type: Article

References (74)

1. Whitaker B, Hinkins S., The 2007 national blood collection and utilization survey report. In:Rockville, MD, :US Department of Health and Human Services; 2007.
2. Devine DV, Serrano K., The platelet storage lesion. Clin Lab Med 2010;30:475–487.
3. European Directorate for the Quality of Medicines and Healthcare. Guide to the preparation, use and quality assurance of blood components. 16th edition. Strasbourg:Council of Europe; 2010.
4. Hussain S, Moiz B, Ausat FA, Khurshid M., Monitoring and reporting transfusion reactions as a quality indicator:A clinical audit. Transfus Apher Sci 2015;52:122–127.
5. Kelley DL, Mangini J, Lopez-Plaza I, Triulzi DJ., The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions. Transfusion 2000;40:439–442.
6. Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J., Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007;47:126–132.
7. Metcalfe P, Williamson LM, Reutelingsperger CP, Swann I, Ouwehand WH, Goodall AH., Activation during preparation of therapeutic platelets affects deterioration during storage:A comparative flow cytometric study of different production methods. Br J Haematol 1997;98:86–95.
8. Skripchenko A, Kurtz J, Moroff G, Wagner SJ., Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008;48:1469–1477.
9. Gyorgy B, Szabo TG, Pasztoi M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al. Membrane vesicles, current state-of-the-art:Emerging role of extracellular vesicles. Cell Mol Life Sci 2011;68:2667–2688.
10. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J., Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006;134:307–313.
11. Boilard E, Duchez AC, Brisson A., The diversity of platelet microparticles. Curr Opin Hematol 2015;22:437–444.
12. van der Grein SG, Nolte-’t Hoen EN., “Small Talk” in the innate immune system via RNA-containing extracellular vesicles. Front Immunol 2014;5:542.
13. Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, Provost P., Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013;122:253–261.
14. Duchez AC, Boudreau LH, Naika GS, Bollinger J, Belleannée C, Cloutier N, Laffont B, Mendoza-Villarroel RE, Lévesque T, Rollet-Labelle E, et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci USA 2015;112:E3564–3573.
15. Chandler WL., Measurement of microvesicle levels in human blood using flow cytometry. Cytometry B Clin Cytom 2015; 90:326–336.
16. Poncelet P, Robert S, Bailly N, Garnache-Ottou F, Bouriche T, Devalet B, Segatchian JH, Saas P, Mullier F., Tips and tricks for flow cytometry-based analysis and counting of microparticles. Transfus Apher Sci 2015;53:110–126.
17. Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, Paré A, Rousseau M, Naika GS, Lévesque T, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014;124:2173–2183.
18. Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ., Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 2016;22:146–153.
19. Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, Shlomchik MJ, Coffman RL, Candia A, Mehal WZ.Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest 2016;126:859–864.
20. Maeda A, Fadeel B., Mitochondria released by cells undergoing TNF-alpha-induced necroptosis act as danger signals. Cell Death Dis 2014;5:e1312.
21. Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU., Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ 2009;16:1438–1444.
22. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P., Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010;330:362–366.
23. Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality:derivation and validation. PLoS Med 2013;10:e1001577; discussion e1001577.
24. Zhao Z, Wang M, Tian Y, Hilton T, Salsbery B, Zhou EZ, Wu X, Thiagarajan P, Boilard E, Li M, et al. Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury-associated coagulopathy in mice. Blood 2016;22:2763–2772.
25. Ernster L, Schatz G., Mitochondria: A historical review. J Cell Biol 1981;91:227s–255s.
26. Wenceslau CF, McCarthy CG, Goulopoulou S, Szasz T, NeSmith EG, Webb RC., Mitochondrial-derived N-formyl peptides:Novel links between trauma, vascular collapse and sepsis. Med Hypotheses 2013;81:532–535.
27. Galluzzi L, Kepp O, Kroemer G., Mitochondria: Master regulators of danger signalling. Nat Rev Mol Cell Biol 2012;13:780–788.
28. Cloonan SM, Choi AM., Mitochondria:Sensors and mediators of innate immune receptor signaling. Curr Opin Microbiol 2013;16:327–338.
29. Lee YL, King MB, Gonzalez RP, Brevard SB, Frotan MA, Gillespie MN, Simmons JD. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns:A potential effector of transfusion-related acute lung injury. J Surg Res 2014;191:286–289.
30. Bakkour S, Acker JP, Chafets DM, Inglis HC, Norris PJ, Lee TH, Busch MP., Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells. Vox Sang 2016;111:22–32.
31. Cognasse F, Aloui C, Anh Nguyen K, Hamzeh-Cognasse H, Fagan J, Arthaud CA, Eyraud MA, Sebban M, Fromont E, Pozzetto B, et al. Platelet components associated with adverse reactions:Predictive value of mitochondrial DNA relative to biological response modifiers. Transfusion 2016;56:497–504.
32. Yasui K, Matsuyama N, Kuroishi A, Tani Y, Furuta RA, Hirayama F., Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects. Transfusion 2016;5:1201–12.
33. Canadian Standards Association CAN/CSA-Z902-10. A National Standard of Canada, Blood and Blood Components. In:Kraegel J, editor. Mississauga, ON; 2010.
34. Mark K., Fung, Brenda J. Grossman, Christopher Hillyer, Connie M. Westhoff. Technical manual. 18th ed. In:Bethesda, MD:AABB Press; 2014.
35. Thibault L, Beausejour A, de Grandmont MJ, Lemieux R, Leblanc JF., Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method. Transfusion 2006;46:1292–1299.
36. Cloutier N, Tan S, Boudreau LH, Cramb C, Subbaiah R, Lahey L, Albert A, Shnayder R, Gobezie R, Nigrovic PA, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components:The microparticle-associated immune complexes. EMBO Mol Med 2013;5:235–249.
37. Rousseau M, Belleannee C, Duchez AC, Cloutier N, Levesque T, Jacques F, Perron J, Nigrovic PA, Dieude M, Hebert MJ, et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS One 2015;10:e0116812.
38. Qiu P, Simonds EF, Bendall SC, Gibbs KD, Jr, Bruggner RV, Linderman MD, Sachs K, Nolan GP, Plevritis SK., Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 2011;29:886–891.
39. Chen TJ, Kotecha N., Cytobank: Providing an analytics platform for community cytometry data analysis and collaboration. Curr Top Microbiol Immunol 2014;377:127–157.
40. Tzima E, Poujol C, Nurden P, Nurden AT, Orchard MA, Walker JH., Annexin V relocates to the periphery of activated platelets following thrombin activation:An ultrastructural immunohistochemical approach. Cell Biol Int 1999;23:629–635.
41. Tamagawa-Mineoka R., Important roles of platelets as immune cells in the skin. J Dermatol Sci 2015;77:93–101.
42. Parida BK, Garrastazu H, Aden JK, Cap AP, McFaul SJ., Silica microspheres are superior to polystyrene for microvesicle analysis by flow cytometry. Thromb Res 2015;135:1000–1006.
43. van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost 2012;10:919–930.
44. Neumuller J, Meisslitzer-Ruppitsch C, Ellinger A, Pavelka M, Jungbauer C, Renz R, Leitner G, Wagner T., Monitoring of platelet activation in platelet concentrates using transmission electron microscopy. Transfus Med Hemother 2013;40:101–107.
45. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P., Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157–164.
46. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ., Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464:104–107.
47. Tynngard N., Preparation, storage and quality control of platelet concentrates. Transfus Apher Sci 2009;41:97–104.
48. Prowse CV, de Korte D, Hess JR, van der Meer PF,; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Commercially available blood storage containers. Vox Sang 2014;106:1–13.
49. Fijnheer R, Pietersz RN, de Korte D, Gouwerok CW, Dekker WJ, Reesink HW, Roos D., Platelet activation during preparation of platelet concentrates:A comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 1990;30:634–638.
50. Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T, Bailey SL, Pellham E., Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution. Transfusion 2014;54:2283–2291.
51. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR., In vivo tracking of platelets:Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996;93:11877–11882.
52. Osman A, Hitzler WE, Meyer CU, Landry P, Corduan A, Laffont B, Boilard E, Hellstern P, Vamvakas EC, Provost P., Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets 2015;26:154–163.
53. Albanyan AM, Murphy MF, Rasmussen JT, Heegaard CW, Harrison P., Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin:A comparison study with annexin V. Transfusion 2009;49:99–107.
54. Albanyan AM, Harrison P, Murphy MF., Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days. Transfusion 2009;49:108–117.
55. Bode AP, Orton SM, Frye MJ, Udis BJ., Vesiculation of platelets during in vitro aging. Blood 1991;77:887–895.
56. Xie RF, Hu P, Li W, Ren YN, Yang J, Yang YM, Wang ZY, Fan HH., The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst. Vox Sang 2014;106:234–241.
57. Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orsó E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, et al. Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets. Transfusion 2015;55:507–521.
58. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ., Activated platelets release two types of membrane vesicles:Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999;94:3791–3799.
59. Johnson L, Reade MC, Hyland RA, Tan S, Marks DC., In vitro comparison of cryopreserved and liquid platelets:Potential clinical implications. Transfusion 2014;4:838–47.
60. Yari F, Azadpour S, Shiri R., Platelet storage media change the expression characteristics of the platelet-derived microparticles. Indian J Hematol Blood Transfus 2014;30:169–174.
61. Nollet KE, Saito S, Ono T, Ngoma A, Ohto H., Microparticle formation in apheresis platelets is not affected by three leukoreduction filters. Transfusion 2013;53:2293–2298.
62. Schwertz H, Koster S, Kahr WH, Michetti N, Kraemer BF, Weitz DA, Blaylock RC, Kraiss LW, Greinacher A, Zimmerman GA, et al. Anucleate platelets generate progeny. Blood 2010;115:3801–3809.
63. Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, Brisson AR., Extracellular vesicles from blood plasma:Determination of their morphology, size, phenotype and concentration. J Thromb Haemost 2014;12:614–627.
64. Rank A, Nieuwland R, Liebhardt S, Iberer M, Grützner S, Toth B, Pihusch R., Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang 2011;100:179–186.
65. Schiffmann E, Corcoran BA, Wahl SM., N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A 1975;72:1059–1062.
66. Carp H., Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 1982;155:264–275.
67. Simmons JD, Lee YL, Mulekar S, Kuck JL, Brevard SB, Gonzalez RP, Gillespie MN, Richards WO., Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg 2013;258:591–596; discussion 596–598.
68. Kung CT, Hsiao SY, Tsai TC, Su CM, Chang WN, Huang CR, Wang HC, Lin WC, Chang HW, Lin YJ, et al. Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med 2012;10:130.
69. Yamanouchi S, Kudo D, Yamada M, Miyagawa N, Furukawa H, Kushimoto S., Plasma mitochondrial DNA levels in patients with trauma and severe sepsis:Time course and the association with clinical status. J Crit Care 2013;28:1027–1031.
70. Sjovall F, Morota S, Frostner EA, Hansson MJ, Elmér E., Cytokine and nitric oxide levels in patients with sepsis–temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS One 2014;9:e103756.
71. Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A., Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 2004;75:995–1000.
72. Kohler C, Radpour R, Barekati Z, Asadollahi R, Bitzer J, Wight E, Bürki N, Diesch C, Holzgreve W, Zhong XY., Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer 2009;8:105.
73. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012;485:251–255.
74. Marques PE, Amaral SS, Pires DA, Nogueira LL, Soriani FM, Lima BH, Lopes GA, Russo RC, Avila TV, Melgaço JG, et al. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 2012;56:1971–1982.